Weigao (01066) Announces Share Repurchase and Updated Treasury Share Holding

Bulletin Express
Feb 05

Shandong Weigao Group Medical Polymer Company Limited (01066) disclosed that on 5 February 2026, 102,000 H shares were repurchased on the Hong Kong Stock Exchange at prices ranging between HKD5.23 and HKD5.36 per share. The total consideration amounted to HKD543,660. This action was made under a repurchase mandate approved on 27 May 2025, which enables the company to repurchase up to 451,560,392 shares.

Following the repurchase, the outstanding issued shares (excluding treasury shares) stood at 4,481,643,924, and the number of treasury shares increased to 40,688,400, keeping the total issued share capital at 4,522,332,324. The shares repurchased are held in treasury, and a moratorium on any new share issuance or transfer of treasury shares is in effect until 8 March 2026 as stipulated under current listing rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10